COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 460
[77] Cooperstock MS, et al. Clinical management of PANDAS,
PANS, and related disorders: consensus recommendations from
the PANDAS/PANS Research Consortium. J Child Adolesc
Psychopharmacol. 2017;27(7):566-573.
[78] Murphy TK, et al. PANDAS and PANS: clinical and bench
research perspectives from invited experts. J Child Adolesc
Psychopharmacol. 2017;27(7):566-573.
[79] Sigra S, et al. PANDAS and PANS: clinical, neuropsychological,
and biological characterization of a monocentric series of
patients and proposal for a diagnostic protocol. J Child Adolesc
Psychopharmacol. 2018;28(2):104-112.
[80] Frankovich J, et al. Multidisciplinary clinic dedicated to
treating youth with pediatric acute-onset neuropsychiatric
syndrome: presenting characteristics of the first 47 consecutive
patients. J Child Adolesc Psychopharmacol. 2015;25(1):38-47.
[81] Calaprice D, et al. A survey of pediatric acute-onset
neuropsychiatric syndrome characteristics and course. J Child
Adolesc Psychopharmacol. 2017;27(7):607-618.
[82] Bauer K, et al. Conceptualizing autoimmune depression as a
novel neuropsychiatric syndrome. Brain Behav Immun.
2022;99:7-13.
[83] Miller AH, Raison CL. The role of inflammation in depression:
from evolutionary imperative to modern treatment target. Nat Rev
Immunol. 2016;16(1):22-34.
[84] Pape K, et al. Immunoneuropsychiatry - novel perspectives on
brain disorders. Nat Rev Neurol. 2019;15(6):317-328.
[85] Pollak TA, et al. The blood-brain barrier in psychosis. Lancet
Psychiatry. 2018;5(1):79-92.
[86] Najjar S, et al. Neuroinflammation and psychiatric illness. J
Neuroinflammation. 2013;10:43.
460
